HUYABIO International Alternatives & Competitors
12 companies similar to HUYABIO International — The leader in globalizing China's biopharma innovation
Companies similar to HUYABIO International
嘉和生物药业有限公司
Genor Biopharma (6998.HK) is an innovative company with a pipeline of therapies covering t...
Shanghai, China
Sinogen Biopharma
Pioneering the path for Chinese biotech to reach the U.S. pharmaceutical landscape, foster...
CASI Pharmaceuticals, Inc.
Bringing life-changing therapeutics to China and the world.
Rockville, United States
Eloxx Pharmaceuticals
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...
Watertown, United States
Rival Readout
Competing with HUYABIO International? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
EpimAb Biotherapeutics, Inc.
Advancing a Best-in-class Bispecific Antibody Format
Shanghai, China
EOC Pharma Group
Empowering cancer care in China through a robust network of global partnerships, innovativ...
Arcturus Therapeutics
A messenger RNA medicines company focused on the development of liver and respiratory rare...
San Diego, United States
Ascendis Pharma
Committed to making a meaningful difference for patients
Denmark
Sitka Biopharma
We're transforming chemotherapies to further benefit patients by enhancing efficacy & impr...
Canada
Centessa Pharmaceuticals
A new kind of pharmaceutical company delivering asset centricity at scale.
Biocidium Biopharmaceuticals
Clinical-stage biopharmaceutical company focused on novel antibiotics, antifungals, and tr...
Canada
Drug Discovery & Development
Strategies and technologies driving drug discovery to market.
Cleveland, United States
About HUYABIO International
HUYABIO International, established in 2004, stands firm as the frontrunner in globalizing China's biopharma innovation. The company's slogan, "The leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China," aptly reflects its core mission. HUYABIO facilitates fa...
Biopharma Innovation, Drug Development, Globalization, China, Biopharmaceuticals, Compound Portfolio, Licensing, Oncology, Cardiology
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around HUYABIO International: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at HUYABIO International on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
